Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Cross Sectional Study
75%
Anticoagulant Agent
54%
Vaccination
53%
Warfarin
50%
Polypharmacy
50%
Nonalcoholic Fatty Liver
50%
Direct Oral Anticoagulant
50%
Atrial Fibrillation
50%
Diabetes Mellitus
50%
Antiinfective Agent
50%
SARS Coronavirus
50%
Severe Acute Respiratory Syndrome
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Diabetic Complication
37%
Cross-Sectional Study
35%
Medication Error
35%
Cross-Sectional Study
31%
Infection
30%
Cannabis
25%
Clinical Pharmacy
25%
Pharmacokinetic
25%
Hemoglobin A1c
25%
Drug Metabolizing Enzyme
25%
Therapeutic Window
25%
Live Attenuated Influenza Vaccine
25%
Prevalence
17%
Liver Enzyme
16%
Non Insulin Dependent Diabetes Mellitus
15%
Maturity Onset Diabetes of the Young
15%
Gastrointestinal Hemorrhage
12%
Enzyme
12%
Coronavirinae
10%
Cohort Study
10%
COVID-19 Vaccine
10%
Antiulcer Agent
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Adverse Effect
9%
Dabigatran
7%
Cerebrovascular Accident
7%
Amoxicillin
7%
Clavulanic Acid
7%
Rivaroxaban
7%
Gamma Glutamyltransferase
5%
Liver Disease
5%
Antidiabetic Agent
5%
Alanine Aminotransferase
5%
High Density Lipoprotein
5%
Triacylglycerol
5%
Lipid
5%
Nursing and Health Professions
Telemedicine
100%
Saudi Arabia
89%
Cross-Sectional Study
82%
Practice Guideline
58%
Primary Health Care
55%
Adherence
55%
Confidence Interval
54%
Stress Ulcer
50%
Diabetes Mellitus
50%
Odds Ratio
50%
Antiinfective Agent
50%
Patient Compliance
50%
Bariatric Surgery
50%
Absorption
50%
Chronic Condition
50%
Medication Error
41%
Cross-Sectional Study
27%
Blood Pressure
25%
National Health and Nutrition Examination Survey
25%
Polypharmacy
20%
Socioeconomic Status
16%
Medline
12%
Systolic Blood Pressure
11%
Diastolic Blood Pressure
11%
Higher Education
11%
Logistic Regression Analysis
10%
Hemoglobin A1c
10%
Education
9%
Gastrointestinal Hemorrhage
9%
Nonsteroid Antiinflammatory Agent
9%
Antiulcer Agent
9%
Corticosteroid
9%
Healthcare System
8%
Amoxicillin
8%
Clavulanic Acid
8%
Antimicrobial Stewardship
8%
Diabetic Complication
7%
Literature Review
6%
Drug Use
6%
Patient Monitoring
6%
Chi Square Test
5%
Non Insulin Dependent Diabetes Mellitus
5%
Patient with Type 2 Diabetes
5%
Patient with Diabetes
5%
Clinical Outcome
5%
Maturity Onset Diabetes of the Young
5%
Medicine and Dentistry
Cross Sectional Study
79%
Roux-en-Y
59%
Sleeve Gastrectomy
54%
Bariatric Surgery
50%
Stress Ulcer
50%
Meta-Analysis
50%
Influenza Vaccine
50%
Gastroplasty
50%
Laparoscopic Sleeve Gastrectomy
50%
Roux-en-Y Gastric Bypass
43%
Antiinfective Agent
25%
Telemedicine
25%
Diabetes Mellitus
25%
Primary Health Care
25%
Patient Compliance
25%
Gastrointestinal Bleeding
21%
Medication Error
17%
Logistic Regression Analysis
15%
Health Care
12%
Polypharmacy
10%
Obesity Medicine
9%
Education
9%
Nonsteroid Antiinflammatory Agent
9%
Antiulcer Agent
9%
Corticosteroid
9%
Adverse Effect
9%
Complications of Diabetes Mellitus
7%
Prevalence
6%
Study Participant
6%
Medicare
6%
Diseases
6%
Proportional Hazards Model
6%
Cohort Analysis
6%
Hazard Ratio
6%
Adverse Event
5%
Maturity Onset Diabetes of the Young
5%
Hemoglobin A1c
5%
Gastroesophageal Reflux
5%
Random Effects Model
5%
Adverse Event
5%
Arm
5%
